ArticleAnnals of medicine and surgery (2012)2026
Misdiagnosis of oropouche virus in cancer patients: mimicry of treatment-related complications.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Misdiagnosis of oropouche virus (OROV) infection in cancer patients is an emerging clinical concern, particularly in regions reporting more than 500 000 cumulative OROV infections. The virus typically presents with fever in nearly 100% of cases, headache in up to 80%, myalgia in 60%, and leukopenia in approximately 40%, creating substantial overlap with chemotherapy-induced myelosuppression, immunotherapy-related toxicities, and radiotherapy-associated inflammatory syndromes. This clinical mimicry often leads to inappropriate antibiotic use, unwarranted hospitalization, and delays or dose modifications in cancer treatment. As OROV transmission expands through vector proliferation and increased human mobility, accurate recognition becomes essential. Incorporating RT-PCR testing into diagnostic pathways for febrile oncology patients in endemic areas can prevent misclassification and preserve continuity of cancer care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.